Bioactive proteins and peptides are recognised as novel therapeutic molecules with varying
biological properties for potential medical applications. Development of protein and peptidebased
therapeutic products for human use is growing steadily as they continue to receive an increasing
rate of approval by the United States Food and Drugs Administration (US FDA). In this short
review, we describe the current status and methodologies involved in the synthesis of protein and
peptide biopharmaceuticals with an emphasis on the drivers and restrains to their exploitation in the
therapeutic products sector.
Keywords: Bioactive peptides, bioactive proteins, therapeutics, biopharmaceuticals, bioprocessing.
Rights & PermissionsPrintExport